
2026 8th International Conference on Advanced Bioinformatics and Biomedical Engineering (ICABB 2026)
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to 2026 8th International Conference on Advanced Bioinformatics and Biomedical Engineering (ICABB 2026) — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
About this event
2026 8th International Conference on Advanced Bioinformatics and Biomedical Engineering (ICABB 2026)
Event Overview
The 2026 8th International Conference on Advanced Bioinformatics and Biomedical Engineering (ICABB 2026) will be held from November 13–15, 2026, in Bangkok, Thailand. This event is co-located with the 2026 10th International Conference on Computational Biology and Bioinformatics (ICCBB 2026), creating a comprehensive platform for academic and industry collaboration. ICABB 2026 aims to provide an interactive forum for researchers, educators, and professionals to present and discuss advancements in bioinformatics, biomedical engineering, and related fields.
1️⃣ Who Attends (BUYERS / ATTENDEES)
ICABB 2026 attracts a diverse audience, including:
- Academic researchers and professors in bioinformatics and biomedical engineering
- Industry professionals from biotechnology, pharmaceuticals, and medical device companies
- Healthcare practitioners and clinical researchers
- Government and policy-makers in healthcare and technology sectors
- Students and early-career scientists seeking networking and collaboration opportunities
- Representatives from research institutions and funding agencies
- Chief Scientific Officers (CSOs) and Research Directors
- Procurement Managers for lab equipment and software
- Business Development Managers in biotech/pharma
- Academic Partnerships Coordinators
- Medical Device Sales and Marketing Teams
2️⃣ Location + Attendee Geographic Origin
Venue: Bangkok, Thailand (Exact venue details pending official release)
Attendee Origin:
- Primary: Asia-Pacific (Thailand, Japan, China, India, South Korea)
- Secondary: North America and Europe (research institutions and multinational corporations)
- Tertiary: Global participants from academia and industry
- Thai universities and research centers
- Japanese and Chinese biotech firms (historical participants)
- Multinational pharmaceutical companies with APAC operations
3️⃣ Audience Reach
Reach Type: Global with strong Asia-Pacific focus
Justification:
- Co-location with ICCBB 2026 expands international appeal
- Previous editions held in Japan attracted global submissions
- Publication partnerships with Scopus and Ei Compendex enhance academic reach
- Thailand's strategic position as a regional hub for medical research
4️⃣ Sample Buyer Company Names + Websites
| Priority | Company | Website | Best Title to Target | Why This is a Good Buyer Fit |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | https://www.thermofisher.com | Director, Bioinformatics Solutions | Major supplier of research equipment and software |
| 2 | Illumina, Inc. | https://www.illumina.com | Senior Marketing Manager, Asia-Pacific | Leader in genomics technologies and bioinformatics tools |
| 3 | Siemens Healthineers | https://www.siemens-healthineers.com | Head of Biomedical Innovation | Key player in medical technology and digital health solutions |
| 4 | National Institutes of Health (NIH) | https://www.nih.gov | International Research Program Director | Government funding and research collaboration opportunities |
| 5 | BD (Becton, Dickinson and Company) | https://www.bd.com | Vice President, R&D - Life Sciences | Medical device and research instrumentation leader |
| 6 | Abbott Laboratories | https://www.abbott.com | Senior Scientist, Biomonitoring | Biomedical diagnostics and research solutions provider |
| 7 | University of Tokyo | https://www.u-tokyo.ac.jp | Dean, Graduate School of Engineering | Representative of leading Asian academic institutions |
| 8 | Lonza Group | https://www.lonza.com | Head of Biologics Research | Biopharmaceutical manufacturing and R&D services |
| 9 | Agilent Technologies | https://www.agilent.com | Application Specialist, Genomics | Provides analytical instruments for life sciences research |
| 10 | King Mongkut's Institute of Technology Ladkrabang | https://www.kmitl.ac.th | Director, Biomedical Engineering Dept. | Thai host institution with regional influence |
Top 5 Recommendations: Thermo Fisher Scientific, Illumina, Siemens Healthineers, NIH, BD
5️⃣ Job Profiles, Industries & Event Type
Target Job Profiles:
- Chief Scientific Officer (CSO)
- Biomedical Engineering Manager
- Director of Research Operations
- Senior Bioinformatician
- Medical Device Regulatory Affairs Manager
- Academic Research Coordinator
- Life Sciences Product Manager
- Biotechnology
- Medical Devices
- Pharmaceuticals
- Education Management
- Higher Education
- Research
- Healthcare Information Technology
6️⃣ Estimated Attendance
Expected Footfall: Not explicitly stated in official materials
Estimation Basis:
- Previous ICABB conferences (2024 Kyoto: ~300-500 attendees)
- Co-location with ICCBB 2026 likely increases numbers by 20-30%
- Average international conference benchmarks for specialized fields
7️⃣ Key Focus Areas & Buyer Engagement
Core Themes:
- Genomic data analysis and computational biology
- Medical imaging and diagnostics engineering
- Drug discovery and development technologies
- Biomedical signal processing and instrumentation
- Translational research and clinical applications
- AI/ML applications in healthcare and biomedicine
- Position as a platform for "research-to-commercialization" partnerships
- Highlight opportunities for co-development and joint research initiatives
- Target procurement decision-makers for lab equipment and software
- Leverage publication opportunities (Scopus/Ei indexed) for academic buyers
8️⃣ Client-Product Fit Note
To refine buyer targeting, please share your client's official website and product specifications. For example:
- If selling lab instrumentation: Prioritize Thermo Fisher, BD, Agilent
- If offering AI-driven diagnostic solutions: Focus on Siemens, Abbott, research institutions
- If providing academic software licenses: Target universities and NIH representatives
- If in biopharma R&D services: Engage Lonza, academic researchers, and government agencies
9️⃣ Final Recommendation
Quality Rating for B2B List Sales: 7.5/10
Pros:
- High academic credibility through Scopus/Ei indexing
- Strong regional representation from Asia-Pacific
- Multinational corporate participation in co-located event
- Clear pathways for research collaboration and commercialization
- Buyer density lower than pure industry trade shows
- Requires careful filtering to isolate corporate decision-makers
- Thai corporate buyer participation needs verification
Data sheet
| Event Name | 2026 8th International Conference on Advanced Bioinformatics and Biomedical Engineering (ICABB 2026) |
| Event Date | November 13–15, 2026 (confirmed in official welcome/news text) |
| Event Status | Upcoming |
| Venue | Venue name not publicly confirmed on the official website at time of research. |
| City | Bangkok |
| State / Region | Bangkok Metropolitan Region |
| Country | Thailand |
| Organizer | ICABB Conference Group (organizer identity as presented on the official site; detailed legal entity not publicly specified in the provided official text) |
| Official Event Website | www.icabb.org |
| Event Type | International academic conference / research and professional meeting |
| Primary Category | Science & Research |
| Secondary Applicable Categories | Medical & Pharma; IT & Technology |
| Audience Reach | Global |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. |
| Attendance Data Reliability | Low for volume metrics; official site confirms event existence, topic, location, dates, submission deadlines, listener registration, and co-location with ICCBB 2026, but not attendee volume. |
| Main Purpose of Event | To provide an interactive forum for presenting and discussing advances in advanced bioinformatics, biomedical engineering, and related computational biology fields, while enabling research collaboration, publication, technical exchange, and professional networking. |
ICABB 2026 is an international conference focused on advanced bioinformatics and biomedical engineering. According to the official event website, the 8th edition will be jointly held with the 10th International Conference on Computational Biology and Bioinformatics (ICCBB 2026) in Bangkok, Thailand. The event supports paper submission, peer review, oral presentation, publication pathways, and listener registration, indicating a mix of authors, presenters, academic delegates, and non-presenting professional attendees.
From a commercial intelligence perspective, this is primarily a research-led conference rather than a large trade exhibition. Its strongest value lies in identifying scientific decision-makers, lab and research leaders, computational biology practitioners, translational medicine stakeholders, and selected industry R&D participants from biotechnology, pharma, medical devices, health-tech, and academic institutions. It is relevant for outreach tied to research tools, scientific software, data platforms, instrumentation, analytical services, biomedical partnerships, and collaborative innovation.
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Academic researchers and principal investigators | Universities, medical schools, research institutes | High influence on software, instrumentation, data-analysis tools, sequencing workflows, and collaboration decisions | Core audience for research platforms, lab solutions, and scientific partnerships |
| Biomedical engineering faculty and lab directors | Engineering departments, translational medicine centers, hospital-affiliated labs | Influence capital equipment, prototyping, device validation, and research service procurement | Relevant for device components, simulation tools, sensors, imaging, and engineering services |
| Computational biology and bioinformatics professionals | Bioinformatics labs, omics centers, biotech R&D teams, research computing groups | Evaluate analytics software, cloud infrastructure, databases, pipelines, and algorithmic platforms | High relevance for software vendors, AI/ML tools, data infrastructure, and outsourced analytics |
| Biotech and pharmaceutical R&D teams | Biotechnology companies, pharma discovery teams, translational research units | Potential buyers of bioinformatics services, preclinical data tools, assay technologies, and research collaborations | Important for scientific sales, co-development, licensing, and technical partnerships |
| Clinical researchers and hospital innovation teams | Academic medical centers, teaching hospitals, clinical research offices | Influence translational tools, diagnostics workflows, data systems, and research collaborations | Relevant for med-tech, health data, informatics, and validation studies |
| Research procurement and lab operations teams | Universities, institutes, hospitals, life-science companies | Direct purchasing authority for equipment, consumables, subscriptions, and services | High-value contacts for suppliers with defined product catalogs and contractable services |
| Graduate students, postdocs, and early-career scientists | Universities and research labs | Lower direct purchasing power; high future-user and influencer value | Useful for product trials, education-led adoption, and long-term account development |
| Association, publication, and scientific community representatives | Academic societies, journal publishers, conference partners | Influence awareness, reputation, and future collaboration channels | Relevant for sponsorships, co-marketing, and community-building strategies |
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Host city | Bangkok | Moderate to high | Expected concentration of local universities, hospitals, research institutes, and Thai life-science stakeholders |
| Host state / region | Bangkok Metropolitan Region | Moderate | Regional attendance likely from nearby academic, hospital, and government-linked research communities |
| Nearby business and research hubs | Thailand-based universities, med-tech, biotech, and health innovation ecosystems | Moderate | Bangkok is a practical access point for Thai and regional Southeast Asian delegates |
| National reach | Thailand-wide academic and research audience | Moderate | National participation is likely, but not quantified by the organizer |
| International reach | Asia-Pacific and broader global research community | High relevance, unknown volume | Official site states participants are welcomed from all over the world; co-location with ICCBB 2026 should increase cross-border relevance |
| Key trade / research corridors | Southeast Asia, East Asia, and international academic collaboration networks | Selective but valuable | Best suited to scientific, institutional, and R&D networking rather than mass-market buyer traffic |
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Primary classification | The official website explicitly welcomes participants from all over the world. The conference topic is internationally relevant and co-location with ICCBB 2026 strengthens cross-border academic and industry participation. |
| Regional | Secondary practical reach | Bangkok is a strong regional gateway for Southeast Asia and may draw significant attendance from surrounding Asian research markets. |
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| No buyer-side organizations publicly listed on the official ICABB 2026 website at time of research | N/A | The official site confirms the event, dates, location, and registration pathways, but does not publish a current attendee list, speaker organizations in the supplied source text, sponsor roster, exhibitor list, or buyer directory. | N/A | Research Director; Principal Investigator; Bioinformatics Lead; Biomedical Engineering Professor; Lab Manager; Procurement Manager | Confirmed current-year event, but buyer organizations not publicly confirmed |
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Director of Bioinformatics | R&D / Bioinformatics | Director | Owns computational biology workflows, analytics tools, and research platform evaluations |
| 2 | Principal Investigator | Research | Senior / Lead | Shapes research direction and influences grants, tools, collaborators, and platform adoption |
| 3 | Research Director | R&D | Director | Strong decision-maker for external collaborations, platforms, instruments, and services |
| 4 | Head of Computational Biology | Data Science / R&D | Head / Director | Critical buyer/influencer for omics, modeling, AI, and biological data analysis solutions |
| 5 | Biomedical Engineering Lab Director | Engineering / Research | Director | Influences instrumentation, device development, validation tools, and technical vendors |
| 6 | Lab Manager | Operations / Laboratory | Manager | Operational buyer for lab systems, consumables, service contracts, and workflow tools |
| 7 | Procurement Manager | Procurement | Manager | Useful where the offer requires formal purchasing, budgeting, or contract approval |
| 8 | Clinical Research Director | Clinical Research | Director | Relevant for translational tools, patient data solutions, and research collaboration programs |
| 9 | Chief Scientific Officer | Executive / Scientific Leadership | C-Level | High-value stakeholder in biotech, diagnostics, and scientific platform partnerships |
| 10 | Data Science Manager | Data Science / Analytics | Manager | Relevant where event participants evaluate AI, modeling, pipelines, and computational infrastructure |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Biotechnology | Direct fit with bioinformatics-driven R&D and translational biology | Scientific software, omics analysis, research partnerships |
| 2 | Pharmaceuticals | Drug discovery and biomarker research depend on advanced bioinformatics | R&D analytics, external scientific services, computational platforms |
| 3 | Medical Devices | Biomedical engineering track aligns with product development and validation needs | Engineering tools, clinical validation, technical collaboration |
| 4 | Research | Core audience includes research institutions and scientific centers | Institutional outreach, grants-aligned product adoption, collaborations |
| 5 | Higher Education | Universities are likely the largest attendee segment | Lab software, teaching tools, instrumentation, research services |
| 6 | Hospital & Health Care | Clinical researchers and hospital innovation units may participate | Clinical informatics, translational tools, analytics |
| 7 | Information Technology & Services | Computational biology relies on software, data pipelines, and IT enablement | Cloud, bioinformatics platforms, implementation services |
| 8 | Computer Software | Strong relevance for scientific analytics, modeling, and AI applications | Platform sales, pipeline automation, data visualization |
| 9 | Government Administration | Possible participation from public research institutions and science agencies | Public-sector research collaborations and grant-funded procurement |
| 10 | Education Management | Relevant for institutions managing academic programs and research operations | Academic partnerships, training, lab and curriculum support |
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Attendance figure not publicly confirmed by the organizer. | Unconfirmed | Official website does not state attendance volume | No reliable estimate should be presented without organizer data |
| Exhibitor count | Not publicly confirmed | Unconfirmed | No exhibitor directory identified in supplied official text | This appears to be conference-led rather than exhibition-led |
| Buyer count | Not publicly confirmed | Unconfirmed | No buyer program or hosted-buyer volume disclosed | Buyer identification must rely on role-based prospecting, not event-published counts |
| Speaker count | Not publicly confirmed in supplied source text | Unconfirmed | Speakers navigation exists on official site, but count not present in provided content | Speaker organizations should be extracted only once officially listed |
| Sponsor count | Not publicly confirmed | Unconfirmed | Sponsor page referenced, but no count in supplied source text | No official sponsor roster available in the provided material |
| Historical attendance | Not publicly confirmed | Historical data unavailable in supplied source text | Official history/news confirms prior editions were held, but not attendance numbers | Prior-year volume should not be estimated without official records |
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Bioinformatics | Data analysis, sequence interpretation, pipeline efficiency, reproducibility | Demo advanced analytics, workflow automation, and data management capabilities | Bioinformatics software, cloud platforms, databases, consulting |
| Biomedical engineering | Research tools, prototype support, device testing, signal or systems engineering | Present technical capabilities tied to engineering validation and applied research | Instrumentation, sensors, engineering software, testing services |
| Computational biology | Modeling, simulation, scalable compute, algorithm development | Target scientific teams building computational workflows or collaborating across institutions | AI/ML tools, high-performance computing support, specialized software |
| Research publication and peer review | Visibility, citation pathway, conference-paper publication | Approach authors and presenters around tools that strengthen research output | Author services, analytical platforms, manuscript support, data repositories |
| Collaboration and networking | Cross-institution partnerships, grant collaboration, industry-academic exchange | Use account-based outreach and meeting requests before and after the event | Partnership programs, CRO services, contract research, strategic alliances |
| Listener registration audience | Learning, discovery, benchmarking, and vendor evaluation | Good fit for educational messaging and low-friction meeting invitations | Training, SaaS trials, introductory platform demos, institutional packages |
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | High | High for research, scientific software, lab, biomedical, and analytics suppliers; lower for general B2B products |
| Decision-maker availability | Medium | Research and technical decision-makers are likely present, but formal procurement contacts may be fewer than at a trade show |
| Data collection potential | Medium | Useful for speaker, committee, author, and institutional targeting once more program data is published |
| Apollo targeting potential | Very High | Strong fit for title-based and industry-based outreach across biotech, pharma, higher education, research, and hospital accounts |
| Geographic targeting potential | High | Bangkok plus broader Asia-Pacific research corridors provide focused regional targeting opportunities |
| Best outreach approach | High | Use scientific credibility, publication alignment, technical value messaging, and meeting requests rather than generic sales pitches |
| Overall lead quality | High | High-value niche event for precise scientific targeting, but not ideal for large-volume buyer-list extraction |
| Best use case | Account-based lead generation | Best for institutional prospecting, scientific partnerships, and technical product outreach |
| Limitations / risks | Medium | Current public data lacks confirmed attendee organizations, attendance figures, and detailed buyer-side rosters |
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Biotechnology; Pharmaceuticals; Medical Devices; Research; Higher Education; Hospital & Health Care; Information Technology & Services; Computer Software; Government Administration; Education Management | Build a high-fit scientific and institutional account universe |
| Departments | Research; Engineering; Information Technology; Operations; Procurement; Education | Capture both scientific users and economic buyers |
| Seniority | C-Level; VP; Director; Head; Manager; Owner (Owner mainly for small specialized biotech firms) | Prioritize authority and technical influence |
| Job titles | Chief Scientific Officer; Research Director; Director of Bioinformatics; Head of Computational Biology; Principal Investigator; Biomedical Engineering Director; Lab Manager; Clinical Research Director; Procurement Manager; Data Science Manager | Best-fit personas aligned to event themes |
| Geography | Thailand; Bangkok; Southeast Asia; Asia-Pacific; selected global research hubs | Reflect event location and likely international science audience |
| Employee size | 11-50; 51-200; 201-500; 501-1,000; 1,001-5,000; 5,001+ | Cover startups, scale-ups, universities, hospitals, and enterprise R&D groups |
| Keywords | bioinformatics, computational biology, genomics, proteomics, biomedical engineering, translational medicine, omics, clinical research, life sciences, sequencing, molecular diagnostics | Increase topical precision in account and contact discovery |
| Technologies, if relevant | Cloud infrastructure, data analysis tools, laboratory information systems, AI/ML platforms (where Apollo data supports tech filters) | Useful for software, analytics, and digital biology vendors |
| Revenue range, if relevant | Mid-market to enterprise for commercial accounts; open for academic/public institutions | Prioritize organizations with budget capacity |
| Company type | Private; Public; Nonprofit; Educational; Government | Captures the full conference ecosystem |
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| ICABB 2026 Official Website | Official event website | Confirmed event title, Bangkok/Thailand location, official website identity, joint holding with ICCBB 2026, purpose of the event, listener registration availability, paper publication options, and contact email | High |
| ICABB 2026 Important Dates section | Official event date page content | Verified submission deadline, acceptance notification deadline, registration deadline, and a date discrepancy showing conference dates as 13/11/2026–14/11/2026 | High for page existence; requires clarification due to internal inconsistency |
| ICABB 2026 News / Welcome text | Official event announcement text | Confirmed broader event date range of November 13–15, 2026 and international participant positioning | High |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to 2026 8th International Conference on Advanced Bioinformatics and Biomedical Engineering (ICABB 2026) — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.